We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Feasibility and accessibility of electronic patient-reported outcome measures using a smartphone during routine chemotherapy: a pilot study.
- Authors
Bae, Woo Kyun; Kwon, Jihyun; Yang, Yaewon; Lee, Ki Hyeong; Han, Hye Sook; Lee, Hyun Woo; Lee, Sang-Cheol; Song, Eun-Kee; Shim, Hyeok; Ryu, Keun Ho; Song, Jemin; Seo, Sungbo; Park, Jong-Hyock
- Abstract
<bold>Purpose: </bold>There is growing interest in integrating electronic patient-reported outcome (PRO) measures into routine oncology practice for symptom monitoring. Here, we evaluated the feasibility and accessibility of electronic PRO measures using a smartphone (PRO-SMART) for cancer patients receiving routine chemotherapy.<bold>Methods: </bold>The proposed PRO-SMART application obtains daily personal health record (PHR) data from cancer patients via a smartphone. An analysis report of cumulative PHR data is provided to the clinician in a format suitable for upload to electronic medical records (EMRs). Cancer outpatients who had received at least two cycles of chemotherapy and who were scheduled for two more cycles were enrolled.<bold>Results: </bold>Between February 2015 and December 2016, 111 patients were screened and 101 of these were included. One-hundred patients used PRO-SMART at least once and were included in the final analysis (90.1% overall accessibility among all screened patients). The number of symptomatic adverse events (AEs) related to chemotherapy recorded in EMRs (mean ± standard deviation [SD]) increased from 0.92 ± 0.80 to 2.26 ± 1.80 (P < 0.001), and grading of AEs increased from 0.81 ± 0.69 to 1.00 ± 0.62 (P = 0.029). After using PRO-SMART, the numeric rating scale for pain (mean ± SD) increased from 0.20 ± 0.72 to 0.99 ± 1.55 (P < 0.001). A patient-reported questionnaire revealed that 64.2% of patients found it useful and 83% found it easy to use.<bold>Conclusions: </bold>This study suggests that the proposed PRO-SMART is feasible and accessible for assessment of symptomatic AEs in cancer patients receiving chemotherapy for a prospective randomized trial.
- Subjects
HEALTH outcome assessment; ELECTRONIC health records; CANCER chemotherapy; ADVERSE health care events; RANDOMIZED controlled trials
- Publication
Supportive Care in Cancer, 2018, Vol 26, Issue 11, p3721
- ISSN
0941-4355
- Publication type
journal article
- DOI
10.1007/s00520-018-4232-z